×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Endologix hits primary endpoints in one-year follow-up data for DETOUR2 trial
Medical Device Network
The trial evaluated Endologix's DETOUR system in patients with long-segment, complex superficial femoral artery (SFA) disease.
2 days ago
DETOUR2 shows Endologix superficial femoral artery bypass on track
BioWorld MedTech
One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC's...
1 day ago
Endologix picks former Medtronic leader as new chief commercial officer
MassDevice
Endologix announced today that it appointed Mike Mathias as its new chief commercial officer (CCO), effective immediately.
2 months ago
One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)
Business Wire
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment...
2 days ago
Endologix initiates postmarket study of the Detour system
Vascular News
The PTAB1 postmarket study evaluates the Detour system's performance in patients with very long (TASC D) SFA lesions. The study plans to enrol...
2 months ago
A True 'Breakthrough' for Endologix
Medical Device and Diagnostic industry
A True 'Breakthrough' for Endologix. The Irvine, CA-based company has won breakthrough device designation from FDA for the ChEVAS system. The designation comes...
5 months ago
Endologix Appoints Mike Mathias as Chief Commercial Officer
Business Wire
Mike is uniquely qualified to lead our global commercial team and continue the strategic development of our commercial plans. His extensive...
2 months ago
Endologix announces the US Centers for Medicare & Medicaid Services granted a Transitional Pass-Through payment ...
Vascular News
Endologix recently announced that the US CMS has granted a Transitional Pass-Through payment for the Detour system.
4 months ago
Here's Why Endologix Plummeted 37% Today
Yahoo Life UK
Shares of Endologix (NASDAQ: ELGX) were down 37% on Friday after the medical device maker announced disappointing earnings at market close...
1 week ago
Endologix's CE Mark for Nellix is Suspended
Medical Device and Diagnostic industry
The suspension follows the Irvine, CA-based company's voluntary recall of the device earlier this month.
5 months ago